99 related articles for article (PubMed ID: 3713252)
1. Cytogenetic modifications of Friend leukemia cells resistant to adriamycin.
Patet J; Huppert J; Fourcade A; Tapiero H
Leuk Res; 1986; 10(6):651-8. PubMed ID: 3713252
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal changes associated with resistance to doxorubicin: correlation with tumorigenicity.
Tapiero H; Patet J; Fourcade A; Huppert J
Anticancer Res; 1986; 6(2):203-8. PubMed ID: 3707056
[TBL] [Abstract][Full Text] [Related]
3. Reversal of resistance to rhodamine 123 in adriamycin-resistant Friend leukemia cells.
Lampidis TJ; Munck JN; Krishan A; Tapiero H
Cancer Res; 1985 Jun; 45(6):2626-31. PubMed ID: 3986800
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the intracellular level and growth inhibition of a new anthracycline 4'O-tetrahydropyranyl-Adriamycin in Friend leukemia cell variants.
Munck JN; Fourcade A; Bennoun M; Tapiero H
Leuk Res; 1985; 9(2):289-96. PubMed ID: 3990336
[TBL] [Abstract][Full Text] [Related]
5. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Goldenberg GJ; Wang H; Blair GW
Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020
[TBL] [Abstract][Full Text] [Related]
6. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
Tapiero H; Fourcade A; Vaigot P; Farhi JJ
Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.
Tapiero H; Munck JN; Fourcade A; Lampidis TJ
Cancer Res; 1984 Dec; 44(12 Pt 1):5544-9. PubMed ID: 6498816
[TBL] [Abstract][Full Text] [Related]
8. A study of chromosome content of Friend virus-induced mouse erythroleukemia cells (clone M2) via karyotype reconstruction.
Mamaeva SE; Tsvileneva NN
Cancer Genet Cytogenet; 1985 Apr; 16(3):199-205. PubMed ID: 3856467
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of four Friend leukemia cell sublines resistant to adriamycin.
Desoize B; Broglio C; Gorisse MC; Briois F; Carpentier Y; Delvincourt C; Dufer J
Anticancer Res; 1994; 14(3A):995-1000. PubMed ID: 8074504
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
Tsuruo T; Iida H; Yamashiro M; Tsukagoshi S; Sakurai Y
Biochem Pharmacol; 1982 Oct; 31(19):3138-40. PubMed ID: 7150340
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
Tapiero H; Boulé D; Trincal G; Fourcade A; Lampidis TJ
Leuk Res; 1988; 12(5):411-8. PubMed ID: 3164087
[TBL] [Abstract][Full Text] [Related]
12. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
13. Karyotypes of the 5-azacytidine-sensitive and -resistant line of AKR mouse leukemia.
Seifertová M
Neoplasma; 1981; 28(3):317-23. PubMed ID: 6170003
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal modifications of a rat glioblastoma cell line during the acquisition and reversal of doxorubicin resistance.
Montaudon D; Benchekroun MN; Londos-Gagliardi D; Robert J
Anticancer Res; 1990; 10(6):1667-75. PubMed ID: 2285241
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic replication studies on murine T-cell leukemias with special consideration to chromosome 15.
Somssich IE; Spira J; Hameister H; Klein G
Chromosoma; 1982; 86(2):197-208. PubMed ID: 6183060
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of harringtonine cytotoxicity by calcium antagonist diltiazem and biscoclaurine alkaloid cepharanthine in adriamycin-resistant P388 murine leukemia and K562 human leukemia cells.
Yamamoto S; Hui PZ; Fukuda Y; Tatsumi K; Mino M
Biochem Int; 1989 Jun; 18(6):1077-83. PubMed ID: 2751676
[TBL] [Abstract][Full Text] [Related]
17. Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Capranico G; Dasdia T; Zunino F
Int J Cancer; 1986 Feb; 37(2):227-31. PubMed ID: 3943921
[TBL] [Abstract][Full Text] [Related]
18. Effect of verapamil on rhodamine 123 mitochondrial damage in adriamycin resistant cells.
Tapiero H; Sbarbati A; Fourcade A; Cinti S; Lampidis TJ
Anticancer Res; 1986; 6(5):1073-6. PubMed ID: 3800316
[TBL] [Abstract][Full Text] [Related]
19. Markedly reduced levels of anthracycline-induced DNA strand breaks in resistant P388 leukemia cells and isolated nuclei.
Capranico G; Riva A; Tinelli S; Dasdia T; Zunino F
Cancer Res; 1987 Jul; 47(14):3752-6. PubMed ID: 3474061
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of resistance to adriamycin in human myelogenous leukemia K562 resistant to adriamycin and in isolated clones.
Tsuruo T; Iida-Saito H; Kawabata H; Oh-hara T; Hamada H; Utakoji T
Jpn J Cancer Res; 1986 Jul; 77(7):682-92. PubMed ID: 3091555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
